MedTrace Logo

Platform Switched Implant and Bone Level Alteration

NCT02867982 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 36

Last updated 2016-08-16

No results posted yet for this study

Summary

This is a two-year prospective randomized clinical study to to evaluate whether the gingival thickness and insertion depth of dental implants have any influence on marginal bone levels changes around platform switched implants.

Conditions

  • Edentulous
  • Bone Resorption

Interventions

PROCEDURE

Subcrestal implant placement

Dental implants placed 2 mm below the alveolar ridge

PROCEDURE

Paracrestal implant placement

Dental implants placed flush to the alveolar ridge

DRUG

prophylactic antibiotics

amoxicillin was used before and after implant surgery for prophylactic reasons

DEVICE

dental implant

dental implants (Ankylos® system,Dentsply Implants Manufacturing GmbH, Mannheim, Germany) were surgically placed into the edentulous alveolar ridge

RADIATION

x-ray examination

radiographies were taken before treatment and at different time point during the follow-up period

Sponsors & Collaborators

  • Dentsply Sirona Implants and Consumables

    collaborator INDUSTRY

  • Beijing University Health Science Center

    lead OTHER

Principal Investigators

  • Xi Jiang, DMD · Peking University school and hospital of stomotology, Department of oral implantology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2019-12-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02867982 on ClinicalTrials.gov